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Abstract: The chemical composition and biological properties correlation in several medicinal and
aromatic plants is still underexplored, especially in its most common form of consumption as tisane.
The present study aims to characterize the organic acids and vitamin E composition of five tisanes
and their extracts by High-Performance Liquid Chromatography coupled to a diode-array detector
(HPLC-DAD) and HPLC coupled to a fluorescence detector techniques, respectively, and the phenolic
composition by HPLC-DAD-ESI/MS (mass spectrometry by electrospray ionization). It also focuses
on their bioactive properties, namely antioxidant, antimicrobial, anti-inflammatory, cytotoxic, anti-
tyrosinase, and anti-diabetic activities. A Principal Component Analysis (PCA) was performed in
order to understand the correlation between the chemical composition and bioactive properties of
the tisanes. The tisane 5 (T5) composed by lemon thyme, tutsan, cloves, and cinnamon, was the
most promising mixture, presenting the lowest values for the lipid peroxidation inhibition, anti-
inflammatory, and anti-diabetic activity. It also presented the highest concentration of phenolic
acids (caffeoylquinic acids derivatives), and flavan-3-ols (catechin derivatives). Only the dry plants
presented tocopherols. For the antihemolytic, antimicrobial, and cytotoxic activity, T2 and T4 (with
lemon thyme) were highlighted as the best herbal mixtures. The PCA proved to be a valid tool to
select the most promising tisane according to the bioactivity. These results suggest that the studied
tisanes can be source of high added-value bioactive compounds with health-promoting effects and
potential for application in the food and nutraceutical industries, among others.
Keywords: medicinal and aromatic plants; herbal teas; tisane; phenolic compounds; bioactives
1. Introduction
Currently, there is a growing interest in medicinal and aromatic plants (MAPs) due to
the various benefits they provide to consumers’ health. MAPs, as natural sources of several
bioactive compounds, have medicinal properties with great potential to be applied for the
treatment of several diseases [1]. Their most common form of consumption is as tisane, or
popularly known as herbal teas or infusions [2].
The active roles of several MAPs upon disease prevention, control, or reduction have
been attributed to the antioxidant features of lypossoluble constituents (such as vitamins
A and E), water-soluble components (such as vitamin C and organic acids), and phenolic
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compounds [3–6]. The antioxidant activity of phenolic compounds is mainly due to their
redox properties, which allow them to act as reducing agents and hydrogen donators [7].
The characterization of phenolic compounds responsible for the different beneficial prop-
erties identified is of great interest for the food and nutraceutical industries, focusing on
numerous applications, such as replacement of artificial antioxidants, development of food
supplements, or nutraceuticals, among others [8,9].
There are several studies indicating that mixtures of MAPs are potentially more
bioactive when compared to isolated plants [9,10]. However, the therapeutic properties that
tisanes prepared from MAPs mixtures may exhibit are still under-explored. In this context,
the present study describes the chemical composition in terms of phenolic compounds,
organic acids, and tocopherols (vitamin E) of five tisanes prepared from mixtures of distinct
MAPs. Furthermore, the antioxidant, antimicrobial, anti-inflammatory, cytotoxic, anti-
tyrosinase, and antidiabetic activities of the five tisanes were also evaluated and correlated
with the presence of the several families of phenolic compounds found. The results obtained
could add value to these tisanes with the potential to be applied in different industrial
sectors.
2. Materials and Methods
2.1. Samples and Tisanes Preparations
Five tisane samples (Figure 1) were kindly provided by the “Cantinho das Aromáticas”
Company, Canidelo—Vila Nova de Gaia, Portugal, in their commercial form (dried and
packed in plastic wrappers). Tisane one (T1) was composed by Cymbopogon citratus (D.C.)
Stapf, Ocimum basilicum “Cinnamon”, and Gomphrena sp.; tisane two (T2) had Thymus x
citriodorus (Pers.) Schreb, Thymus mastichina L., Lavandula angustifolia Mill, and Gomphrena
globosa L.; tisane three (T3) was composed by Agastache foeniculum (Pursh) Kuntze, Mentha
x piperita L., and Mentha spicata L.; tisane four (T4) had Rosmarinus officinalis L., Ocimum
basilicum L., Thymus x citriodorus (Pers.) Schreb, Calendula officinalis L., and Mentha x piperita
L.; finally, tisane five (T5) was composed by Hypericum androsaemum L., Thymus x citriodorus
(Pers.) Schreb, Cinnamomum zeylanicum Blume, and Syzygium aromaticum L. The MAPs
that make up the tisanes were produced following the principles of organic production
(certified by ECOCERT, Leiria, Portugal) and do not contain caffeine (information provided
by the company). Some of the biological activities that the studied plants exhibits are
described in Table 1. The dried samples were reduced to a fine homogeneous powder
(~20 mesh) and stored in a cool dry place. The tisanes were prepared by adding 2 g of each
dried sample to 50 mL of boiling distilled water (100 ◦C), allowing them to stand for 5 min
at room temperature and then filtering them through a filter paper. The obtained tisanes
were frozen and lyophilized, then stored in a dry place at room temperature and protected
from light before further analysis.
Foods 2021, 10, 475 3 of 26
Foods 2021, 10, x FOR PEER REVIEW 2 of 24 
 
 
A and E), water-soluble components (such as vitamin C and organic acids), and phenolic 
compounds [3–6]. The antioxidant activity of phenolic compounds is mainly due to their 
redox properties, which allow them to act as reducing agents and hydrogen donators [7]. 
The characterization of phenolic compounds responsible for the different beneficial prop-
erties identified is of great interest for the food and nutraceutical industries, focusing on 
numerous applications, such as replacement of artificial antioxidants, development of 
food supplements, or nutraceuticals, among others [8,9].  
There are several studies indicating that mixtures of MAPs are potentially more bio-
active when compared to isolated plants [9,10]. However, the therapeutic properties that 
tisanes prepared from MAPs mixtures may exhibit are still under-explored. In this con-
text, the present study describes the chemical composition in terms of phenolic com-
pounds, organic acids, and tocopherols (vitamin E) of five tisanes prepared from mixtures 
of distinct MAPs. Furthermore, the antioxidant, antimicrobial, anti-inflammatory, cyto-
toxic, anti-tyrosinase, and antidiabetic activities of the five tisanes were also evaluated and 
correlated with the presence of the several families of phenolic compounds found. The 
results obtained could add value to these tisanes with the potential to be applied in dif-
ferent industrial sectors. 
2. Materials and Methods 
2.1. Samples and Tisanes Preparations 
Five tisane samples (Figure 1) were kindly provided by the “Cantinho das Aromát-
icas” Company, Canidelo—Vila Nova de Gaia, Portugal, in their commercial form (dried 
and packed in plastic wrappers). Tisane one (T1) was composed by Cymbopogon citratus 
(D.C.) Stapf, Ocimum basilicum “Cinnamon”, and Gomphrena sp.; tisane two (T2) had Thy-
mus x citriodorus (Pers.) Schreb, Thymus mastichina L., Lavandula angustifolia Mill, and Gom-
phrena globosa L.; tisane three (T3) was composed by Agastache foeniculum (Pursh) Kuntze, 
Mentha x piperita L., and Mentha spicata L.; tisane four (T4) had Rosmarinus officinalis L., 
Ocimum basilicum L., Thymus x citriodorus (Pers.) Schreb, Calendula officinalis L., and Mentha 
x piperita L.; finally, tisane five (T5) was composed by Hypericum androsaemum L., Thymus 
x citriodorus (Pers.) Schreb, Cinnamomum zeylanicum Blume, and Syzygium aromaticum L. 
The MAPs that make up the tisanes were produced following the principles of organic 
production (certified by ECOCERT, Leiria, Portugal) and do not contain caffeine (infor-
mation provided by the company). Some of the biological activities that the studied plants 
exhibits are described in Table 1. The dried samples were reduced to a fine homogeneous 
powder (~20 mesh) and stored in a cool dry place. The tisanes were prepared by adding 2 
g of each dried sample to 50 mL of boiling distilled water (100 °C), allowing them to stand 
for 5 minutes at room temperature and then filtering them through a filter paper. The 
obtained tisanes were frozen and lyophilized, then stored in a dry place at room temper-

















Gomphrena sp.   





















Thymus x citriodorus (Pers.) 
Schreb 
Thymus mastichina L. 
Lavandula angustifolia 
Mill 









Agastache foeniculum (Pursh) 
Kuntze 












Rosmarinus officinalis L.  Ocimum basilicum L.  
Thymus x citriodorus 
(Pers.) Schreb  










Hypericum androsaemum L. 




Syzygium aromaticum L.  
Figure 1. Description of the medicinal and aromatic plants (MAPs) that constituted the five sam-
ples tisanes. 
Table 1. Applicability, common uses, and biological properties of the MAPs that constituted the five samples tisanes. 
Plant Family Applicability/Com-
mon Uses 
Bioactive Properties Ref. 
Agastache foeniculum 
(Pursh) Kuntze 
Lamiaceae Medicine  Antimicrobial [11] 
Calendula officinalis L. Asteraceae 
Cosmetic, medicinal, 






icum Blume Lauraceae Food 
Antitumor and antidia-
betics [13] 
Figure 1. Description of the m dicinal and aro ati plants (MAPs) that constituted t e five samples tisan .
Foods 2021, 10, 475 4 of 26
Table 1. Applicability, common uses, and biological properties of the MAPs that constituted the five samples tisanes.
Plant Family Applicability/Common Uses Bioactive Properties Ref.
Agastache foeniculum
(Pursh) Kuntze Lamiaceae Medicine Antimicrobial [11]
Calendula officinalis L. Asteraceae Cosmetic, medicinal, food, andcolorant
Anti-inflammatory,
antitumor, and antimicrobial [12]
Cinnamomum zeylanicum
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The lyophilized tisane extracts were re-dissolved in water to obtain a solution of
5 mg/mL and to determine the phenolic profiles by chromatographic analysis using a
Dionex Ultimate 3000 UPLC (Thermo Scientific, San Jose, CA, USA) [26]. Detection was
carried out with a diode array detector (DAD) using 280 nm, 330 nm, and 370 nm as
the preferred wavelengths and connected in line with a Linear Ion Trap LTQ XL mass
spectrometer (Thermo Finnigan, San Jose, CA, USA) equipped with an electrospray
ionization (ESI) source and working in negative mode. Data acquisition was carried
out with an Xcalibur® data system (Thermo Finnigan, San Jose, CA, USA). The phe-
nolic compounds were identified through the available standard compounds and by
using literature information regarding the fragmentation pattern. Quantification was
performed using 5-level calibration curves obtained from available commercial standard
compounds: apigenin-6-C-glucoside (y = 107,025x + 61,531, R2 = 0.9989, LOD = 0.19 µg/mL;
LOQ = 0.63 µg/mL); apigenin-7-O-glucoside (y = 10,683x − 45,794, R2 = 0.996,
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LOD = 0.10 µg/mL; LOQ = 0.53 µg/mL); caffeic acid (y = 388,345x + 406,369, R2 = 0.9939,
Limit of detection (LOD) = 0.78 µg/mL; Limit of quantification (LOQ) =1.97 µg/mL); cate-
quin (y = 84,950x – 23,200, R2 = 0.999, LOD = 0.17 µg/mL; LOQ = 0.68 µg/mL); chlorogenic
acid (y = 168,823x − 161,172, R2 = 0.9999, LOD = 0.20 µg/mL; LOQ = 0.68 µg/mL); cinnamic
acid (y = 1 × 106x − 222,204, R2 = 0.9993, LOD = 0.33 µg/mL and LOQ = 1.19 µg/mL); fer-
ulic acid (y = 633,126x − 185,462, R2 = 0.999, LOD = 0.20 µg/mL; 1.01 µg/mL); naringenin
(y = 18,433x + 78,903, R2 = 0.9998, LOD = 0.17 µg/mL; LOQ = 0.81 µg/mL); p-coumaric acid
(y = 301,950x + 6966.7, R2 = 0.9999, LOD = 0.68 µg/mL and LOQ = 1.61 µg/mL); quercetin-
3-O-glucoside (y = 34,843x − 160,173, R2 = 0.9998, LOD = 0.21 µg/mL; LOQ = 0.71 µg/mL);
quercetin-3-O-rutinoside (y = 13,343x + 76,751, R2 = 0.9998, LOD = 0.14 µg/mL; LOQ =
0.45 µg/mL); rosmarinic acid (y = 191,291x − 652,903, R2 = 0.999, LOD = 0.15 µg/mL;
LOQ = 0.68 µg/mL); and syringic acid (y = 376,056x + 141,329, R2 = 0.9995, LOD =
0.23 µg/mL and LOQ = 0.72 µg/mL). The results were expressed in mg/g of extract.
2.2.2. Organic Acids and Tocopherols (Vitamin E)
The organic acids were analyzed by ultra-fast liquid chromatography coupled to a
photodiode array detector programmed to record at 215 nm as the preferred wavelength
(UFLC-PDA; Shimadzu Coperation, Kyoto, Japan) [27]. The identification and quantifica-
tion of the individual organic acids was performed by comparison to authentic standards
and by comparison of the peak area in the programmed wavelength. Standard calibration
curves for organic acids quantification: oxalic acid (y = 9 × 106x + 45,973, R2 = 0.9901,
LOD = 12.55 µg/mL; LOQ = 41.82 µg/mL); quinic acid (y = 610,607x + 46,061, R2 = 0.9995,
LOD = 24.18 µg/mL; LOQ = 80.61 µg/mL); malic acid (y = 912,441x + 92,665, R2 = 0.999,
LOD = 35.76 µg/mL; LOQ = 119.18 µg/mL); and fumaric acid (y = 154,862x + 1 × 106,
R2 = 0.9977, LOD = 0.08 µg/mL; LOQ = 0.26 µg/mL). The results were expressed in g per
100 g of dry weight for dry plants and in mg per 100 mL of infusion preparations.
Tocopherols were determined using HPLC coupled to a fluorescence detector (FP-
2020; Jasco, Easton, MD, USA) programmed for excitation at 290 nm and emission at
330 nm [12]. The identification was performed by chromatographic comparisons with
authentic standards, while the quantification was based on the fluorescence signal response
of each standard, using the internal standard (tocol) method and by using calibration
curves obtained from commercial standards of each compound. The results were expressed
in g per 100 g of dry weight for dry plants and in mg per 100 mL for infusion preparations.
2.3. Evaluation of Bioactive Properties
2.3.1. Antioxidant Activity
The antioxidant activity was evaluated through the lipid peroxidation inhibition using
porcine brain cell homogenates by using the thiobarbituric acid reactive substances (TBARS)
assay [28] and oxidative hemolysis inhibition assay (OxHLIA) [29]. The lyophilized tisane
extracts were re-dissolved in water to obtain stock solution of 0.3 mg/mL, which were
further diluted to obtain a range of seven concentrations below the stock solution for the
TBARS assay. For OxHLIA, the lyophilized tisane extracts were re-dissolved in PBS, while
water was used for complete hemolysis and PBS solution as the control. The results were
expressed as IC50 values (µg/mL), with the sample concentration providing 50% of lipid
peroxidation inhibition or extract concentration required to keep 50% of the erythrocyte
population intact for ∆t of 120 and 180 min, respectively. Trolox was used as a positive
control.
2.3.2. Antimicrobial Activity
The lyophilized tisane extracts were re-dissolved in water to obtain a stock solution
of 20 mg/mL, while the samples were serially diluted obtain the concentration ranges
(20 at 0.15 mg/mL). The antimicrobial activity was evaluated using five Gram-negative
bacteria: Escherichia coli, Proteus mirabilis, Klebsiella pneumoniae, Pseudomonas aeruginosa, and
Morganella morganii, and three Gram-positive bacteria: Enterococcus faecalis, Listeria monocy-
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togenes, and methicillin-resistant Staphylococcus aureus (MRSA). The Minimum Inhibitory
Concentration (MIC) and the Minimum Bactericidal Concentration (MBC) were performed
using the colorimetric assay of p- iodonitrotetrazolium [30]. Three negative controls were
prepared (one with Mueller Hinton Broth/ Tryptic Soy Broth (MHB)/(TSB), another one
with the extract, and the third with medium, antibiotic, and bacteria). One positive control
was prepared with MHB/TSB and each inoculum. Ampicillin and Imipenem were used for
all Gram-negative bacteria tested and Listeria monocytogenes. Ampicillin and vancomycin
were selected for Enterococcus faecalis and MRSA.
2.3.3. Anti-Inflammatory Activity
The anti-inflammatory potential was evaluated by producing nitric oxide formed in
the mouse macrophage-like cell line RAW 264. 7 [28]. The lyophilized tisane extracts were
re-dissolved in water to obtain stock solutions of 8 mg/mL, which were further diluted
to obtain a range of six concentrations below the stock solution. For the determination
of nitric oxide, a Griess Reagent System kit was used, which contains sulphanilamide,
N-(1-napthyl)ethylenediamine hydrochloride (NED), and nitrite solutions. A reference
curve of nitrite (sodium nitrite 100 mM to 1.6 mM; y = 0.0063x + 0.1368; R2 = 0.9989) was
prepared in a 96-well plate. The nitric oxide produced was determined by measuring the
absorbance at 540 nm (microplate reader ELX800 Biotek), and by comparison with the
standard calibration curve. The results were expressed in IC50 values (µg/mL), which
correspond to the sample concentration providing 50% of inhibition of nitric oxide (NO)
production. Dexamethasone was used as a positive control.
2.3.4. Cytotoxic and Hepatotoxic Activity
The lyophilized tisane extracts were re-dissolved in water to obtain stock solution of
8 mg/mL, which were further diluted to obtain a range of six concentrations below the stock
solution. HepG2 (hepatocellular carcinoma), NCI-H460 (non-small cell lung carcinoma),
HeLa (cervical carcinoma), and MCF-7 (breast adenocarcinoma) were used as human tumor
cell lines. Non-tumor cells were also tested; a cell culture (named as PLP2) was prepared
from a freshly harvested porcine liver obtained from a local slaughterhouse, according to a
procedure established by the authors. Sulforhodamine B assay was performed according
to a procedure previously described by the authors [28]. Ellipticine was used as a positive
control and the results were expressed in GI50 values (µg/mL), which correspond to the
sample concentration providing 50% of inhibition of cell growth.
2.3.5. Anti-Tyrosinase Activity
The tyrosinase inhibitory activity of each lyophilized herbal tea extract was determined
using the SPECTROstar Nano Multi-Detection Microplate Reader and 96-well plates (BMG
Labtech, Ortenberg, Germany) [31]. Absorbance was measured at 475 nm, and results
are expressed as IC50 or percentage of inhibition (when the sample is not active enough
to calculate an IC50 value for the tested concentration of 8 mg/mL) using the following
calculation formula: % I = ((AB) − (CD))/((AB)) × 100. Kojic acid solution (0.10 mg/mL)
was used as a positive control.
2.3.6. Antidiabetic Activity
The capacity of inhibition α-glucosidase (from yeast and rat) was measured in a 96-well
microplate reader [32,33]. The lyophilized tisane extracts were re-dissolved in water to obtain
a stock solution of 8 mg/mL. Acarbose was used as a positive control. The results were
expressed as IC50 values (µg/mL) or percentages of inhibition (when the sample is not active
enough to calculate an IC50 value for the tested concentration of 8 mg/mL) using the following
calculation formula: Inhibition (%) = ((Abscontrol − Absort)/Abscontrol) × 100.
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2.4. Statistical Analysis
For each extract and its infusion, all the assays were carried out in triplicate. The
results were expressed as mean values and standard deviation (SD) and analyzed using one-
way analysis of variance (ANOVA) followed by Tukey’s HSD test with p = 0.05 (except for
the analysis of anti-inflammatory activity results, in which a Student’s t-test was used, with
α = 0.05) using IBM SPSS Statistics for Windows, Version 23.0. (IBM Corp., Armonk, NY,
USA). For the PCA analysis, a categorical principal component analysis (CATPCA) with
optimal scaling was used to explore the joint relationships between the five tisanes in study
and their phenolic composition and bioactive capacity. The number of plotted dimensions
(two) was chosen in order to allow meaningful interpretations and was assessed by the
respective eigenvalues (should be greater than one), the Cronbach’s alpha (must be positive)
and the total percentage of variance (should be as higher as possible) explained by the
selected data.
3. Results and Discussion
3.1. Phenolic Compounds
The five tisanes presented a very distinct phenolic compounds profile (Table 2). How-
ever, it was possible to group the identified phenolic compounds into five different families:
phenolic acids, isoflavones, flavanones, flavonoids, and flavan-3-ols, and quantify them
accordingly, as is shown in Table 3.
Twenty-nine phenolic acids (caftaric acid, syringic, coutaric, p-coumaric, fertaric,
caffeic, chicoric, rosmarinic acids, and their derivatives), 21 flavonoids (C-glycosylated
apigenin derivatives and O-glycosylated kaempherol, luteolin, quercetin, isorhamnetin,
chrysoeriol, apigenin, and diosmetin derivatives), four isoflavones (O-glycosylated ca-
lycosin and derivatives), three flavanones (O-glycosylated eriodictyol derivatives), two
flava-3-ols (B-type (epi)catechin trimer and tetramer), and three non-phenolic compounds
(medioresinol derivatives and oleanolic acid derivative), were tentatively identified in the
tisanes samples studied. Two unknown compounds were also found in tisanes T3 and T5.
As previously stated, the tentative identification of the phenolic and non-phenolic
compounds was performed comparing the DAD-MS results with available commer-
cial standards and by comparison with data reported in the literature. Table 2 pro-
vides a description of the methodology used for the identification of each compound
in which bibliographic references report the chromatographic data of the compound in
question in detail, for valid identification. An effort was also performed to try to recon-
cile the references with the individual plant matrices present in each sample; however,
it was not possible to achieve this for many of the compounds. The bibliographic ref-
erences that have plant matrices in common to those studied in the present work were
Miguel et al. [50] and Pires et al. [38], who studied the flowers of marigold; Rita et al. [51]
and Roriz et al. [52] presented the phenolic profile of lemongrass, lemon thyme [51],
and G. globosa [52]; Pereira et al. [53] studied the phenolic profile of pepper mint and
Ribeiro et al. [45] studied the phenolic profile of rosemary. All of these bibliographic
references were also used for identification of many of the phenolic compounds reported
herein.
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Table 2. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, and tentative identification of phenolic and non-phenolic compounds
found in the tisanes prepared from five MAP mixtures (T1, T2, T3, T4, and T5).
Peak Rt (min) λmax (nm) [M-H]− (m/z) MS2 (m/z) Tentative Identification
Reference/Method
Used for Identification
1 4.75 263/325 311 179(72),149(100),135(5) Caftaric acid [33]
2 4.79 324 353 191(100),179(49),173(10),135(12) 3-O-Caffeoylquinic acid DAD/MS [34,35]
3 5.5 280 359 197(100),153(8),113(5) Syringic acid hexoside [36]
4 5.81 312 295 163(100),149(5),119(5) Coutaric acid [33]
5 6.31 264 325 163(100),119(18) p-Coumaric acid hexoside [37]
6 6.62 324 353 191(80),179(9),173(100),135(5) cis 4-O-Caffeoylquinic acid [34,35]
7 6.67 290/321 325 193(100),149(5),134(5) Fertaric acid [33]
8 7.06 285 611 449(100),287(13) Eriodictyol-O-dihexoside [33]
9 7.11 324 353 191(100),179(5),173(5),135(5) trans 4-O-Caffeoylquinic acid [34,35]
10 7.87 325 353 191(100),179(9),173(5),135(5) cis 5-O-Caffeoylquinic acid [34,35]
11 8.41 281 387 369(25),207(100),163(41),119(5) Medioresinol [38,39]
12 8.54 321 353 191(100),179(12),173(5),135(5) trans 5-O-Caffeoylquinic acid [34,35]
13 9.95 325 593 473(100),383(13),353(21),325(5) Apigenin-C-hexoside-C-hexoside [40]
14 10.05 322 179 135(100) Caffeic acid DAD/MS
15 11.1 281 865 739(83),713(50),695(100),577(77),425(12),407(10),289(5),287(12) Type B (epi)-catechin trimer [41]
16 11.44 279 325 163(100),145(5),119(8) p-Coumaric acid hexoside [37]
17 12.12 283 1153 865(37),577(12),561(5),289(5),287(5) Type B (epi)-catechin tetramer [41]
18 12.22 327 473 311(100),293(98),179(61),149(80),135(5) cis Chicoric acid [42]
19 12.3 327 473 311(100),293(95),179(50),149(55),135(5) trans Chicoric acid [42]
20 12.59 324 637 461(100),285(15) Kaempherol-O-diglucuronide DAD/MS
21 13.46 346 637 285(100) Luteolin-O-diglucuronide DAD/MS
22 14.47 330 555 537(100),493(12),359(10),179(5),161(5) Salvianolic acid K isomer [43]
23 14.5 285/325 537 493(100),359(34),313(13),295(4),269(3),197(5),179(5) Lithospermic acid A [44]
24 15.16 284 595 287(100) Eriodictyol-O-deoxyhexosyl-hexoside [45]
25 15.18 341 477 301(100) Quercetin-O-glucuronide [46]
26 15.8 344 463 301(100) Quercetin-3-O-glucoside DAD/MS
27 15.99 282 463 287(100) Eriodictyol-O-glucuronide DAD/MS
28 16.96 342 769 315(100) Isorhamnetin-O-di-deoxyhexosyl-hexoside [46]
29 17.37 322 521 359(100),197(45),179(40),161(15),135(5) Rosmarinic acid hexoside [44]
30 17.69 343 609 301(100) Quercetin-3-O-rutinoside DAD/MS
31 17.98 345 593 285(100) Luteolin-O-deoxyhexosyl-hexoside [45]
32 18.02 346 593 285(100) Luteolin-7-O-rutinoside DAD/MS
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Table 2. Cont.
Peak Rt (min) λmax (nm) [M-H]− (m/z) MS2 (m/z) Tentative Identification
Reference/Method
Used for Identification
33 18.07 348 477 301(100) Quercetin-O-glucuronide [46]
34 18.38 347 461 285(100) Luteolin-7-O-glucoside DAD/MS
35 18.93 347 461 285(100) Luteolin-O-glucuronide [46]
36 18.57 280 717 519(100),475(20),339(7),321(5) Salvianolic acid B [44]
37 18.96 281/327 487 325(90),307(51),293(100),193(5),179(12) Feruloylcaffeoyl tartaric acid [38]
38 19.2 347 521 359(100),197(44),179(38),161(14),135(5) Rosmarinic acid hexoside [44]
39 19.29 282/323 719 539(24),521(17),339(100),197(10),179(5),161(5),135(5) Sagerinic acid [44]
40 19.85 337 717 537(40),519(100),493(5),359(10),339(5),321(5),295(5),197(5),179(5) Salvianolic acid B isomer [44]
41 20.17 340 549 505(100),301(10) Quercetin-O-malonylhexoside DAD/MS
42 21.92 330 359 197(29),179(36),161(100),135(5) Rosmarinic acid DAD/MS
43 22.25 325 555 537(5),511(8),493(45),311(100),197(5),179(5),161(5),135(5) Salvianolic acid K [43]
44 23.92 340 533 489(100),285(10) Luteolin-O-malonylhexoside DAD/MS
45 24.05 341 549 387(100),369(21),207(50),163(41),119(5) Medioresinol caffeate [38,39]
46 24.71 333 461 285(100) Luteolin-O-glucuronide [46]
47 25.51 335 475 299(100),285(5) methylluteolin-O-hexuronide (chrysoeriolhexuronide) [47]
48 25.85 331 717 537(10),519(100),493(5),359(5),339(21),321(50),295(9),197(5),179(5) Salvianolic acid B isomer [44]
49 25.97 324 537 493(100),359(10),313(6),295(6),269(5),197(5),179(5) Lithospermic acid A [44]
50 28.17 330 517 473(20),269(100) Apigenin-O-malonylhexoside DAD/MS
51 29.02 331 503 285(100) Luteolin-O-malonylpentoside DAD/MS
52 29.71 341 547 503(50),299(100) Diosmetin-O-malonylhexoside DAD/MS
53 30.17 284/329 537 493(100),439(51),197(24),179(6),359(20) Lithospermic acid A isomer 2 [44]
54 30.48 280/339 493 359(100),313(15),295(9),269(7),197(5),179(5) Salvianolic acid A [45]
55 30.84 330 503 285(100) Luteolin-O-malonylpentoside DAD/MS
56 33 268/331 677 659(21),451(100),367(10),225(20) Unkwown -
57 34.19 290 791 773(100),678(11),546(2),451(35),337(2),225(11) Oleanolic acid derivative [48]
58 35.77 268/333 1063 771(100),283(50),269(10) Unkwown -
59 36.87 338 589 545(100),299(5) Diosmetin-malonyl methyl hexoside DAD/MS
60 38.08 269/329 283 269(100) Calycosin [49]
61 40.01 269/329 573 283(100) Calycosin derivative DAD/MS
62 40.36 268/329 533 283(100) Calycosin derivative DAD/MS
63 41.83 268/330 573 283(100) Calycosin derivative DAD/MS
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Table 3. Quantification (mg/g of extract) of the phenolic and non-phenolic compounds present in tisanes prepared from five MAP mixtures (mean ± SD).
Peak T1 T2 T3 T4 T5 t-Students Testp-Value
1 A 0.41 ± 0.01 nd nd nd nd -
2 B nd nd nd nd 3.13 ± 0.14 -
3 C nd 0.163 ± 0.002 nd nd nd -
4 D 0.143 ± 0.001 nd nd 0.151 ± 0.002 nd 0.001
5 E nd 0.863 ± 0.01 nd 0.29 ± 0.01 nd <0.001
6 B nd nd 0.69 ± 0.02 nd 0.63 ± 0.03 <0.001
7 F 0.172 ± 0.002 nd nd nd nd -
8 G nd 0.086 ± 0.004 nd 0.115 ± 0.004 nd -
9 B nd nd 1.19 ± 0.02 nd 30.88 ± 1.17 <0.001
10 B nd nd nd nd 3.66 ± 0.01 -
11 D nd 0.215 ± 0.004 nd nd nd -
12 B nd nd nd nd 2.07 ± 0.06 -
13 H nd 1.016 ± 0.003 a nd 0.606 ± 0.002 b 0.442 ± 0.001 c -
14 A 0.1303 ± 0.002 nd 0.15 ± 0.01 nd nd 0.001
15 I nd nd nd nd 1.65 ± 0.03 -
16 E nd 1.07 ± 0.03 nd nd nd -
17 I nd nd nd nd 1.98 ± 0.76 -
18 A 2.69 ± 0.05 nd nd 0.263 ± 0.004 nd <0.001
19 A 0.82 ± 0.01 nd nd 0.49 ± 0.02 nd <0.001
20 J nd tr nd nd nd -
21 J nd nd 2.47 ± 0.04 2.27 ± 0.08 nd <0.001
22 K 2.33 ± 0.01 nd nd 1.29 ± 0.01 nd <0.001
23 K nd nd 0.747 ± 0.004 nd nd -
24 G nd nd 6.49 ± 0.23 5.77 ± 0.12 nd <0.001
25 J nd 1.52 ± 0.03 nd nd 0.90 ± 0.01 <0.001
26 L nd 4.58 ± 0.18 nd nd nd -
27 G nd nd nd 1.996 ± 0.003 3.17 ± 0.07 -
28 J nd nd nd 1.19 ± 0.01 nd -
29 K nd 1.99 ± 0.01 nd nd nd -
30 J 0.23 ± 0.003 nd nd 1.59 ± 0.01 nd -
31 J nd nd nd 3.533 ± 0.003 nd -
32 J nd nd 5.91 ± 0.02 nd nd -
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Table 3. Cont.
Peak T1 T2 T3 T4 T5 t-Students Testp-Value
33 J nd nd nd nd 2.29 ± 0.01 -
34 L nd 8.73 ± 0.11 d 7.05 ± 0.13 c 10.08 ± 0.22 b 15.92 ± 0.34 a -
35 L nd 3.17 ± 0.04 nd nd 8.09 ± 0.25 <0.001
36 K 0.61 ± 0.01 nd nd nd nd -
37 F 0.107 ± 0.004 nd nd nd nd -
38 K nd 6.12 ± 0.12 1.23 ± 0.02 nd nd <0.001
39 K 0.828 ± 0.013 c nd nd 1.84 ± 0.05 a 1.55 ± 0.07 b -
40 K nd nd 1.71 ± 0.07 1.79 ± 0.01 nd <0.001
41 J 1.19 ± 0.05 nd nd nd nd -
42 K 10.84 ± 0.14 d 20.78 ± 0.34 b 22.65 ± 0.33 a 20.66 ± 0.26 b 19.9 ± 0.13 c -
43 K nd 9.60 ± 0.39 nd nd nd -
44 J nd nd 0.278 ± 0.005 nd nd -
45 D nd nd 3.16 ± 0.02 nd nd -
46 J nd nd 1.19 ± 0.04 0.88 ± 0.03 nd <0.001
47 J nd 0.68 ± 0.01 nd nd nd -
48 K nd nd 3.34 ± 0.02 5.46 ± 0.19 nd -
49 K 6.84 ± 0.09 a nd nd 1.14 ± 0.03 c 5.61 ± 0.09 b -
50 M nd nd 1.03 ± 0.01 nd nd -
51 J nd nd nd 0.40 ± 0.02 nd -
52 G nd nd 36.04 ± 0.05 nd nd -
53 K nd nd nd 0.95 ± 0.01 nd -
54 K 2.59 ± 0.03 nd nd nd 0.87 ± 0.01 <0.001
55 J nd nd nd 0.080 ± 0.001 nd -
56 nd nd nq nd nd -
57 nd nd nd nd nq -
58 nd nd nq nd nd -
59 G nd nd 0.026 ± 0.001 nd nd -
60 K nd nd 1.07 ± 0.06 nd nd -
61 K nd nd 0.25 ± 0.01 nd nd -
62 K nd nd 7.28 ± 0.13 nd nd -
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Table 3. Cont.
63 K nd nd 9.22 ± 0.21 nd nd -
TPA 28.51 ± 0.28 e 40.59 ± 0.13 b 31.73 ± 0.23 d 34.34 ± 0.10 c 68.30 ± 0.78 a -
TiF nd nd 17.81 ± 0.14 nd nd -
TFa nd 0.086 ± 0.004 d 6.495 ± 0.23 b 7.88 ± 0.12 a 3.17 ± 0.07 c -
TFo 1.42 ± 0.05 e 19.7 ± 0.3 d 53.98 ± 0.08 a 20.58 ± 0.19 c 27.66 ± 0.08 b -
TF3O nd nd nd nd 3.64 ± 0.04 -
TOC nd 0.215 ± 0.004 3.16 ± 0.02 nd nd <0.001
TPC 29.93 ± 0.34 e 60.58 ± 0.45 d 113.19 ± 0.68 a 62.79 ± 0.41 c 102.78 ± 0.84 b -
nd—not detected; tr—traces; nq—non quantifiable. TPA—Total Phenolic acids; TiF—Total isoflavones; TFa—Total flavanones: TFo—Total flavonoids; TF3O—Total flavan-3-ol; TOC—Total other compounds;
TPC—Total phenolic compounds. Standard calibration curves used for quantification in each peak: A—caffeic acid; B—chlorogenic acid; C—syringic acid; D—cinnamic; E—p-coumaric acid; F—ferulic acid;
G—naringenin; H—apigenin-6-C-glucoside; I—catequin; J—quercetin-3-O-rutinoside; K—rosmarinic acid; L—quercetin-3-O-glucoside; and M—apigenin-7-O-glucoside. ANOVA analysis—In each row different
letters mean significant differences (p < 0.05).
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Regarding the concentrations (mg/g of extract) of the various families of compounds
in each tisane (Table 3), it was found with regard to flavonoids, the vast majority of com-
pounds were glycosylated derivatives of luteolin (peaks 21, 31, 34, 35, 44, 46, and 52), pre-
ceded by glycosylated quercetin derivatives (peaks 25, 26, 30, 33, and 41), except for T3 sam-
ples. The highest concentration of glycosylated derivatives of luteolin and quercetin were
found in T2/T4 samples (peak 34) and T2 (24), respectively. The glycosylated derivatives
of kaempherol were only identified in tisane T2 (peak 20, kaempherol-O-diglucuronide)
and in trace amounts. Regarding the glycosylated derivative of isorhamnetin, it was exclu-
sively identified in T4 sample (peak 28, isorhamnetin-O-di-deoxyhexosyl-hexoside). There
are several references regarding the bioactive properties of this family of phenolic com-
pounds, the most relevant of which are its anti-inflammatory, anti-tumor, and antioxidant
properties [54].
The glycosylated derivatives of eriodictyol were the only flavanones tentatively identi-
fied in the tisanes samples (except in the T1 sample, where were not flavanones identified).
The highest concentration of total flavanones was found for T4 samples (7.876 mg/g of
extract, due to the presence of the peaks 24 and 27) as shown in Table 3.
3.2. Organic Acids and Tocopherols
The results for the characterization of organic acids and tocopherols in mixtures of
dried tisanes (extracts) and infusions preparations are shown in Table 4.
The content and composition in organic acids and tocopherols vary according to the
typology of different plant tissues, since the production of these compounds depends on the
edaphoclimatic conditions of plant growth, namely light, salinity, and temperature [46,53].
Regarding the organic acid content, it was noted that the composition is very similar in
all tisane samples, both in dry extracts and in infusion preparations, with oxalic, quinic,
malic, and fumaric acids being identified. However, T1 samples (dry extract and infusion
preparation) presented the highest concentrations of these compounds (4.59 g/100 g dry
weight and 234 mg/100 mL, respectively), mainly due to the presence of oxalic acid. Sample
T5 presented the lowest levels of organic acids, all of them in the trace form. Fumaric acid
presented the lowest expression of all identified organic acids and was only detected in the
T5 tisane.
Regarding the tocopherol composition (Table 3), as expected, these molecules were
identified only in the dry extracts, and no isoforms were detected in the infusion prepara-
tions. These molecules are fat soluble and their extraction with water is inefficient, having a
low affinity with this type of extraction solvent [55]. Therefore, it can be stated that tisanes
from extracts of the MAP mixtures studied are not sources of tocopherols (vitamin E). Con-
cerning the dry extracts, only two isoforms (α and γ) were detected, with the γ-tocopherol
isoform being the most outstanding. The total content of tocopherols varied significantly
among all tisane samples, with T1 extract presenting a higher amount of α-tocopherol
(12.2 mg/100 g of dry weight), and T5 extract presenting a higher amount of γ-tocopherol
(109 mg/100 g dry weight), which significantly affected its total content. Consequently, T5
tisane revealed the highest concentration of total tocopherols (112 mg/100 g dry weight).
In C. Citratus, oxalic, malic, ascorbic, succinic, and fumaric acids have already been
described by Roriz [10], but in the tisane where this plant is present, ascorbic, succinic and
fumaric acids have not been detected, possibly due to competitiveness in the face of the
other two plants that are present in T1 samples (O. basilicum “Cinnamon” and Gomphrena
sp.). Oxalic and malic acids have also been previously described in Gomphrena sp. by
Liberal et al. [15].
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Table 4. Characterization of organic acids and tocopherols in mixtures of dried tisanes (extracts) and infusions preparations (mean ± SD).
Extracts Infusion Preparations
T1 T2 T3 T4 T5 T1 T2 T3 T4 T5
Organic acids (g/100 g·dw) (mg/100 mL)
Oxalic acid 2.47 ± 0.01 a 0.38 ± 0.002 d 1.30 ± 0.02 b 0.79 ± 0.01 c tr 98 ± 1 a 6.9 ± 0.1 d 16.8 ± 0.3 c 21.1 ± 0.5 b tr
Quinic acid 1.65 ± 0.07 a 0.10 ± 0.04 d 1.00 ± 0.08 c 1.33 ± 0.09 b nd 69 ± 1 a 2.8 ± 0.1 d 28 ± 1 c 33 ± 1 b nd
Malic acid 0.48 ± 0.03 a 0.36 ± 0.02 d 0.41 ± 0.01 c 0.43 ± 0.01 b tr 68 ± 1 a 11.5 ± 0.3 b 11 ± 1 b 10.5 ± 0.1 c tr
Fumaric acid nd nd nd nd tr nd nd nd nd tr
Sum 4.59 ± 0.09 a 0.83 ± 0.07 d 2.71 ± 0.08 b 2.54 ± 0.09 c tr 234 ± 3 a 21.2 ± 0.4 d 56 ± 2 c 65 ± 1 b tr
Tocopherols (mg/100 g·dw) (mg/100 mL)
α-Tocopherol 12.2 ± 0.9 a 3.3 ± 0.3 c 0.87 ± 0.01 e 3.5 ± 0.2 b 2.3 ± 0.1 d nd nd nd nd nd
γ-Tocopherol 35.8 ± 0.4 b nd 4.71 ± 0.01 d 11.2 ± 0.3 c 109 ± 5 a nd nd nd nd nd
Sum 48.0 ± 0.6 b 3.3 ± 0.3 e 5.58 ± 0.01 d 14.7 ± 0.3 c 112 ± 5 a nd nd nd nd nd
dw—dry weight basis; nd—not detected; tr—traces. ANOVA analysis—In each row different letters mean significant differences (p < 0.05).
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Oxalic acid was the compound identified in the vast majority of aqueous extracts and
preparations (except for T4 tisane extract and T3 and T4 aqueous preparation). This organic
acid has the ability to inhibit the lipase enzyme and, consequently, to reduce the occurrence
of physiological problems such as type II diabetes [56]. On the other hand, quinic acid is
considered as a powerful antioxidant, having a stronger performance than the synthetic
antioxidant BHT (butylated hydroxyl toluene) [57]. Regarding malic acid, it participates in
the Krebs cycle and therefore has an essential role in human metabolism, having also been
shown to have a bactericidal effect [58,59]. The use of organic acids in the food industry
is a sustainable and natural alternative and can be used as a preservative, antioxidant,
flavoring and acidifier [58], and their presence in tisanes may confer bioactive properties
on a daily intake basis.
Vitamin E is composed of four isoforms (α—alpha, β—beta, γ—gamma, and δ—delta),
and its most biologically active isoform is α-tocopherol, therefore the most necessary in
the human diet. The isoform α is responsible for 50% of the attributed antioxidant action,
while the isoform β has 25–50% and the isoforms γ and δ has between 10–35% [60].
Two of the plants that make up the T1 tisane have already been studied individually
regarding their composition in tocopherols. In 2014, Roriz [10] reported the presence of
the isoforms α and γ tocopherol in C. citratus, with α-tocopherol being the isoform present
in the highest concentration. In turn, Liberal et al. [15] identified the same isoforms for
Gomphrena sp., with γ-tocopherol being the most abundant isoform. On the third plant
that makes up the T1 tisane (O. basilicum “Cinnamon”), there is no data regarding the
composition in tocopherols. In the study carried out by Roriz [10], antagonistic effects
were described in mixtures of MAPs as being responsible for differentiating the content
in bioactive compounds, namely tocopherols and organic acids, depending on the con-
centration of the plants. This may explain the differences in relation to the C. citratus
plant, since its concentration in T1 tisane may possibly be insignificant and therefore the
same composition and content in tocopherols and organic acids was not obtained when
compared with the literature.
Regarding the T5 tisane, Ramadan, Asker, and Tadros [60] identified the four isoforms
of tocopherol (α, β, γ and δ) in the essential oil of Syzygium aromaticum (cloves) in expressive
quantities, with the isoform α- the predominant. In 2015, Gandomani et al. [61] reported
an increase in the levels of α-tocopherol in egg yolk when supplementary powder from
the sprout of the S. aromaticum plant was added, thus indicating the major contribution of
the isoform in this species. For H. androsaemum, it was not possible to find published data
related to the content in tocopherols. However, Hosni, Msaâda, Taârit, and Marzouk [62] re-
ported the isoforms α, γ, and δ-tocopherol in four species belonging to the genus Hypericum
and identified δ-tocopherol as the most abundant isoform, although its amount presented
great variations depending on the species. It was also not possible to find data regarding
the content of tocopherols in T. citrodorus; however, this plant also belongs to the order
Lamiales, which predominantly presents the isoforms α and γ, as previously mentioned.
According to the national reference of food composition, the National Institute Dr. Ricardo
Jorge [63], cinnamon (Cinnamomum zeylanicum) has 0.1 g of total tocopherol for every 100 g
of edible part. Thus, the dried extracts from the tisanes can be considered as sources of this
type of bioactive compounds and, therefore, can be used in various applications, namely
nutraceuticals.
3.3. Evaluation of Bioactive Properties
3.3.1. Antioxidant Activity
The results of the antioxidant activity assays are described in Table 5 and are expressed
as IC50 (µg/mL). In the OxHLIA assay, IC50 values were given at two-time intervals (∆t),
since natural extracts contain different antioxidant molecules capable of interacting with
each other and favoring the protection of cell membranes at different time periods. The five
tisanes samples tested showed antioxidant capacity for both assays performed. All showed
significant differences, except T3 and T4 tisanes for the TBARS assay, probably because
Foods 2021, 10, 475 16 of 26
they have a common plant (Mentha x piperita L.) in the composition of their respective
extracts that contributed to this activity, as described by Pereira et al. [53]. For the OxHLIA
assay, the tisane that presented the best antioxidant activity, and consequently the best
antihemolytic action, was the T2 sample, at 120 and 180 min, with an IC50 of 17.8 µg/mL
and 30.3 µg/mL, respectively. This result suggests that the compounds present in tisane T2
can reduce hemolytic action by 50% for 120 min and extend for an additional 60 min. For
TBARS, the most active tisane was the T5 sample with an IC50 of 5.07 µg/mL, that is the
minimum concentration capable of inhibiting 50% of lipid peroxidation. In both assays
performed, the lowest activity was shown by the T1 sample.
The IC50 obtained for both assays was lower than the standards used, as shown in
Table 5, making these tisanes promising sources of compounds with antioxidant capacity.
Similar results were observed for herbal tea plants that have common plants, such as
tisanes T2, T5, and T3 with lemon thyme (T. citriodorus).
In the OxHLIA assay, the antioxidant activity was found in the following order: T2
> T3 > T5 in 120 min and T2 > T5 > T3 in 180 min. The inversion of bioactivity presented
between T3 and T5 for the times of 120 and 180 min is probably due to the fact that these two
herbal teas have different antioxidant molecules depending on the other plants that make
up the mixture of herbal teas (in T3 with anise and mint, and in T5 with St. John’s wort,
cinnamon and cloves). In the TBARS test, the results of antioxidant activity were ordered
as follows: T5 > T2 > T3 = T4, since T3 and T4 have one plant in common (peppermint).
The mechanisms of antioxidant activity related to cells are believed to be through the
capture of free radicals and the alteration of cell membrane properties, often due to phenolic
compounds, in particular, flavonoids. Some of these compounds can be incorporated into
the hydrophobic core of the membrane bilayer, causing a reduction in the fluidity and
stability of the membrane. The reduction in fluidity can limit the diffusion of free radicals
and improve the antioxidant efficacy of flavonoids; however, how the solubility of these
compounds affects the stability of the cell membrane remains uncertain [64].
Therefore, the conviction of the antioxidant activity of plant matrices related to the
composition and quantity of phenolic compounds is reinforced. The presence of phenolic
acids confers the ability to inhibit lipid peroxidation in pig brain tissues (TBARS), as they
exhibit a high antioxidant activity, being grouped into benzoic acids (such as synergic acid,
p-hydroxybenzoic acid, and gallic acids) and cinnamic acids (as an example: p-coumaric,
ferulic, and caffeic acids), and it can also bond with each other or with other compounds to
form potential structures, such as chlorogenic acid (a combination of caffeic acid and quinic
acid). The antioxidant potential of phenolic compounds is strongly correlated with the
number of hydroxyl groups attached to the aromatic rings. In addition, hydroxyl groups in
the ortho and para position increase the anti-oxidative and anti-radical activity of phenolic
acids [64].
Foods 2021, 10, 475 17 of 26
Table 5. Bioactive properties of the five tisanes prepared from five MAP mixtures (mean ± SD).
T1 T2 T3 T4 T5
Antioxidant Activity (IC50 values, µg mL) A
OxHLIA ∆t = 120 27.9 ± 0.2 a 17.8 ± 0.2 e 22.0 ± 0.2 d 25.2 ± 0.3 b 23.4 ± 0.3 c
∆t = 180 45.3 ± 0.3 a 30.3 ± 0.3 e 36.5 ± 0.2 c 37.3 ± 0.2 b 34.4 ± 0.7 d
TBARS inhibition 13.2 ± 0.3 a 7.4 ± 0.1 c 9.7 ± 0.3 b 9.8 ± 0.1 b 5.07 ± 0.04 d
Antimicrobial activity (mg/mL) B MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Gram-negative bacteria
Escherichia coli 20 >20 20 >20 >20 >20 >20 >20 20 >20
Klebsiella pneumoniae 20 >20 20 >20 >20 >20 >20 >20 >20 >20
Morganella morganii >20 >20 20 >20 >20 >20 >20 >20 >20 >20
Proteus mirabilis >20 >20 >20 >20 >20 >20 >20 >20 >20 >20
Pseudomonas aeruginosa >20 >20 20 >20 >20 >20 >20 >20 >20 >20
Gram-positive bacteria
Enterococcus faecalis 10 >20 20 >20 5 >20 10 >20 >20 >20
Listeria monocytogenes 5 >20 >20 >20 5 >20 20 >20 >20 >20
MRSA 10 >20 2.5 >20 10 >20 5 >20 10 >20
Anti-inflammatory activity (IC50 values µg/mL) C
RAW 264.7 >400 >400 >400 354 ± 6 * 345 ± 9 *
Cytotoxicity Activity (GI50 values µg/mL) D
HepG2 311 ± 9 a >400 299 ± 9 b 264 ± 15 c 316 ± 13 a
NCI H460 257 ± 9 b >400 >400 248 ± 10 c 317 ± 8 a
HeLa 294 ± 14 b >400 >400 253 ± 8 c 313 ± 5 a
MCF7 320 ± 3 a >400 >400 308 ± 13 b 285 ± 10 c
Hepatotoxicity (GI50 values µg/mL) D
PLP2 >400 >400 >400 >400 >400
Anti-tyrosinase (IC50 values mg/mL or PI at 8 mg/mL) E
Mushroom tyrosinase inhibition >8 >8 >8 >8 >8
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Table 5. Cont.
T1 T2 T3 T4 T5
Antidiabetic activity (IC50 values µg/mL or PI at 8 mg/mL) F
Mammalian α-glucosidase inhibition >8 >8 >8 >8 37 ± 6
Yeast α-glucosidase inhibition 41% ± 4% 1.19 ± 0.02 43% ± 3% 6.9 ± 0.4 0.054 ± 0.003
A Trolox IC50 values: 5.8 ± 0,6 µg/mL (TBARS), 41 ± 3 µg/mL (OxHLIA 120 min) and 64 ± 2 µg/mL (OxHLIA 180 min); B Amoxicillin/Clavulanic Acid (E. Coli ≤ 8/4, S; K. pneumoniae ≤ 8/4, S; K. pneumoniae
ESBL ≥ 32, R; M. morganii > 16/8, R); E Amikacin (E. Coli ESBL 16, I); F Vancomycin (E. faecalis, MRSA, and MSSA ≤ 2, S); G Ampicillin (L. monocytogenes ≤ 0.2, S). S—susceptible; I—intermediate; R—resistant.
This classification was made according to the interpretative breakpoints suggested by Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing
(EUCAST); C Dexamethaxone IC50 value: 16 ± 1 µg/mL; D Ellipticine GI50 values: 1.1 ± 0.2 µg/mL (HepG2), 1.03 ± 0.09 µg/mL (NCI-H460), 1.91 ± 0.06 µg/mL (HeLa), 0.91 ± 0.04 µg/mL (MCF-7), and 3.2 ±
0.7 µg/mL (PLP2); E Kojic acid IC50 values: 0.078 ± 0.001 µg/mL; F Acarbose IC50 values: 0.83 ± 0.02 µg/mL (yeast) and 0.86 ± 0.01 µg/mL (rat). In each row and for the different extraction procedure, different
letters mean significant differences (p < 0.05). * p-value resulting from the Student t test: <0.001. MIC—minimum inhibitory concentration. MBC—minimum bactericidal concentration.
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3.3.2. Antimicrobial Activity
Data on antimicrobial activity based on minimum inhibitory concentrations (MIC)
and minimum bactericidal concentrations (MBC) are shown in Table 5. The highest an-
timicrobial potential for Gram-positive bacteria was showed by tisane T3 (values of 5 to
10 mg/mL for minimal inhibition), except for methicillin-resistant Staphylococcus aureus
(MRSA) for which the most active herbal tea was sample T2. In general, tisane T2 was the
only one that had a minimum inhibitory concentration of 20 mg/mL for Gram-negative
bacteria, while for the other tisanes (T1, T3, T4, and T5) higher concentrations would have
required 20 mg/mL to inhibit the growth of this type of bacteria. The tisane T5 was found
to be the lowest potential tisane because it exhibited the highest MIC and MBC values. All
tisanes (T1, T2, T3, T4, and T5) inhibits the bacterial growth of some of the bacteria tested,
but none has bactericidal activity.
The antimicrobial activity of aqueous extracts is promising, since organic extracts may
present cytotoxicity to the human organism. However, the concentration required for the
activity presented by the herbal tea tested in the present study is still relatively high when
compared to the same organic extracts [45,46].
Cushnie and Lamb [65] described the antimicrobial capacity of flavonols/flavones
(apigenin, naringenin, luteoline, isoflavones, flavanones, quercetin, and their glycosylated
derivatives), as these types of molecules show activity against several bacterial strains. This
statement agrees with the results obtained in the present work, since the T3 tisane sample
presented higher antibacterial capacity for Gram-positive bacteria and, in turn, showed a
higher concentration of flavonols/flavones.
3.3.3. Anti-Inflammatory Activity
The results for the anti-inflammatory activity are shown in Table 5. Only two tisanes
showed anti-inflammatory action, namely T5 and T4, and the first showed higher activity
with an IC50 of 345 µg/mL. The other three tisanes (T1, T2, and T3) presented concentrations
above 400 µg/mL, not revealing anti-inflammatory properties.
It was already described in the literature that the individual plants that make up the
tisanes mixtures have anti-inflammatory activity, such as C. citratus [10], G. globosa [15,66],
T. mastichina [67], Mentha x piperita [19], R. officinalis [23,68], O. basilicum [20], C. offici-
nalis [12], H. androsaemum [16], and Syzygium aromaticum [69]. However, in most cases
extracts are obtained using organic solvents.
Jabeur et al. [16] reported the inhibition of nitric oxide production by H. androsaemum
hydroethanolic extract (plant present in tisane T5), indicating an anti-inflammatory action
for the same trial performed in the present study and it was correlated with the significant
amount of chlorogenic acid derivatives present in the extract. These results are in agreement
with the results obtained in this study, since in T5 the trans forms of neochlorogenic acid
(3-O-caffeoylquinic acid), cis and trans cryptochlorogenic (4-O-caffeoylquinic), and cis and
trans forms of chlorogenic acid (5-O-caffeoylquinic) were significantly quantified.
There are other compounds present in tisane T5, which are also attributed to the
bioactive property in question, such as luteolin. According to Sung and Lee [70], this
flavonoid also exhibits anti-inflammatory properties by suppressing nitric oxide production.
Regarding the T4 sample, apigenin, luteolin, coumaric acid, and quercetin were identified
as potentially anti-inflammatory compounds, which were referred to above. Although
samples T2 and T3 contain some of these compounds as chlorogenic acid, luteolin, and
apigenin, these tisanes were not promising sources of anti-inflammatory activity, possibly
due to the occurrence of synergistic reactions between the various compounds identified
and the low concentration of the compounds referred to as anti-inflammatory potentials
when compared to T4 and T5. Therefore, the MAP mixtures present in T4 and T5 have
positive effects against inflammatory diseases, although relatively high concentrations are
required.
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3.3.4. Cytotoxic and Hepatotoxic Activity
The results for the four human tumor cell lines and primary culture of non-tumor pig
cells are shown in Table 5. The highest cytotoxic capacity was observed for lung carcinoma
tumor cell line (NCl H460). The T4 sample was the tisane with the highest cytotoxic
potential, as the lowest GI50 values were observed for three of the four tumor cell lines
tested: lung carcinoma (248 µg/mL), cervical adenocarcinoma (HeLa, 253 µg/mL), and
hepatocellular carcinoma (HepG2, 264 µg/mL), respectively. For the MCF-7 (human breast
adenocarcinoma) cell line, the most cytotoxic tisane was T5 with GI50 = 285 µg/mL. The
tisane T2 did not show cytotoxic potential for any of the tumor cell lines tested, although
it has in its composition lemon thyme (T. citriodorus), which is also present in T4 and
T5 extracts, thus reinforcing the important need for further studies on the synergistic
and antagonistic effects on mixtures of MAPs in tisanes preparations marketed. The
hepatotoxicity was also evaluated for all the samples (Table 4), and a concentration higher
than 400 µg/mL was observed in all tisanes, which means that no sample revealed toxicity
against PLP2 cells.
The literature describes the cytotoxicity of the individual plants present in the tisane
T4. Pereira et al. [53] observed promising effects in the methanolic extract of peppermint
(M. piperita) for the same tumor cell lines. For the marigold sample (C. officinalis), it
was described by Miguel et al. [50] that this shows cytotoxic activity for the same lines
with values greater than 250 µg/mL. The aqueous extract of rosemary did not show
antiproliferative effects against tumor cell lines when studied by Gonçalves et al. [71],
exposing that the anticancer effects attributed to this plant come from diterpenes [72],
which were not identified in the tisane T4. However, the cytotoxic capacity shown by this
herbal tea may be related to the other plants belonging to the mixture.
3.3.5. Anti-Tyrosinase Activity
The results of the anti-tyrosinase activity assay based on the inhibition of the tyrosi-
nase enzyme from mushrooms are described in Table 5. The results were expressed as a
percentage of inhibition of the enzyme action at a maximum concentration of 8 mg/mL
(maximum concentration tested). All samples of herbal teas (T1, T2, T3, T4, and T5) did not
show inhibition capacity of the tyrosinase enzyme at the maximum tested concentration of
8 mg/mL.
Tisanes are not able to specifically inhibit this enzyme from mushrooms. Tyrosinase
is an enzyme that contains copper and is widely distributed in microorganisms, animals
and plants. Tyrosinase from mushrooms has now become popular because it is widely
available [73] and is able to inhibit the formation of neuromelanin associated with the
development of Parkinson’s (PD) [74]. The inhibition of this enzyme is one of the main
strategies for the treatment of hyperpigmentation, since several dermatological disorders,
such as melasma, age spots, and actinic damage, result from the accumulation of an
excessive level of epidermal pigmentation, and, therefore, compounds tyrosinase inhibitors
have become increasingly important to be incorporated into cosmetic products [72–74].
Currently, new sources are sought, preferably natural ones, which are capable of inhibiting
tyrosinase, since the inhibitor compounds most commonly used by the industry have many
limitations, such as low activity and high cytotoxicity [75].
3.3.6. Antidiabetic Activity
Data on antidiabetic activity based on inhibition of α-glucosidase of fungal and
animal origin are shown in Table 5. The α-glucosidase inhibitors are an important class
of antidiabetic drugs that prevent the sudden increase in hyperglycemia after meals [76].
The tisanes T1 and T3 did not present a minimum inhibition concentration of 50% of
fungal α-glucosidase, therefore, the percentage inhibition was calculated as previously
mentioned and demonstrated the ability to inhibit the action of α-glucosidase by 41% and
43%, respectively. The tisane T5 showed the best antidiabetic activity for fungal origin and
the only one that presented satisfactory concentration for inhibition of 50% of the enzyme
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of animal origin. The tisanes T1, T2, T3, and T4 were not sufficiently active for animal
activity at the maximum tested concentration of 8 mg/mL.
No data were found for antidiabetic activity for the plants that make up the tisane T5;
however, Adisakwattana et al. [77] described the inhibitory activity of potent α-glucosidase
for Orthosiphon aristatus belonging to the Lamiaceae family, which corresponds to the
same family of T. citriodorus (lemon thyme) present in tisane T5. Among polyphenols,
chlorogenic acid has received much attention for several biological activities including
excellent inhibition of α-amylase and type II diabetes-linked α-glucosidase [78]. This is in
accordance with the present study, since in the T5 sample, the most abundant compounds
are chlorogenic acids (CGA) and derivatives.
3.4. Selecting the Most Promisssing Tisane
A principal component analysis was performed in order to better understand the
correlations between the phenolic and non-phenolic compounds composition with the
bioactive properties in the five studied tisanes samples. The biplot illustrated by Figure 2,
joints the relations between precisely the five tisanes (object scores) and their phenolic
composition and bioactive properties (component loadings). The first two-dimensions
(first: Cronbach’s α, 0.917; eigenvalue, 7.308; second: Cronbach’s α, 0.864; eigenvalue,
5.359) account for most of the total variance (40.8% and 26.1%, respectively).




Figure 1. Biplot of object scores (plant tisanes, blue dots) and component loadings (families of phe-
nolic compounds and some bioactive properties, black dots) from CATPCA. The first two dimen-
sions (first: Cronbach's α, 0.917; eigenvalue, 7.308; second: Cronbach's α, 0.864; eigenvalue, 5.359) 
account for most of the variance. 
The first dimension was effective in separating the tisanes samples while taking into 
account their content in phenolic and non-phenolic compounds; the second dimension 
was effective in separating the tisanes by their antioxidant and cytotoxic activity, but was 
particularly effective in the separation of samples by their antidiabetic yeast activity and 
antimicrobial action against L. monocytogenes and E. faecalis.  
T3 sample is positively correlated with the family of compounds TF (total flavo-
noids), ToC (total other compounds), and TPC (total phenolic compounds), meaning that 
this sample present the highest concentrations, while being negatively correlated with the 
bacterial strains L. monocytogenes and E. faecalis (presenting the lowest MIC values, and for 
that manner the highest antibacterial activity against this strains). TPA (total phenolic ac-
ids) is strongly correlated with the T5 sample and is moderately correlated with T2 sam-
ples; these two samples’ negative correlation with the vast majority of the bioactive activ-
ities studied means lower IC50, GI50, and MIC values, and therefore indicates higher bio-
active potential.  
4. Conclusions 
Comparatively the phenolic composition of tisanes and phenolic acids were the fam-
ily of compounds that stood out the most (primarily in the T5 sample), due to the presence 
of chlorogenic acid and rosmarinic acid and their derivatives, both qualitative and quan-
titative (with the exception of the T3 sample in which there were higher levels of flavo-
noids). In turn, the family of flavonoids also stood out in all of them, due to the presence 
of glycosylated derivatives of apigenin, kaempherol, quercetin, luteolin, diosmetin, and 
Figure 2. Biplot of object scores (plant tisanes, blue dots) and component loadings (families of pheno-
lic compounds and some bioactive properties, black dots) from CATPCA. The first two dimensions
(first: Cronbach’s α, 0.917; eigenvalue, 7.308; second: Cronbach’s α, 0.864; eigenvalue, 5.359) account
for most of the variance.
The first dimension was effective in separating the tisanes samples while taking into
account their content in phenolic and non-phenolic compounds; the second dimension
was effective in separating the tisanes by their antioxidant and cytotoxic activity, but was
particularly effective in the separation of samples by their antidiabetic yeast activity and
antimicrobial action against L. monocytogenes and E. faecalis.
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T3 sample is positively correlated with the family of compounds TF (total flavonoids),
ToC (total other compounds), and TPC (total phenolic compounds), meaning that this
sample present the highest concentrations, while being negatively correlated with the
bacterial strains L. monocytogenes and E. faecalis (presenting the lowest MIC values, and for
that manner the highest antibacterial activity against this strains). TPA (total phenolic acids)
is strongly correlated with the T5 sample and is moderately correlated with T2 samples;
these two samples’ negative correlation with the vast majority of the bioactive activities
studied means lower IC50, GI50, and MIC values, and therefore indicates higher bioactive
potential.
4. Conclusions
Comparatively the phenolic composition of tisanes and phenolic acids were the family
of compounds that stood out the most (primarily in the T5 sample), due to the presence of
chlorogenic acid and rosmarinic acid and their derivatives, both qualitative and quantita-
tive (with the exception of the T3 sample in which there were higher levels of flavonoids).
In turn, the family of flavonoids also stood out in all of them, due to the presence of
glycosylated derivatives of apigenin, kaempherol, quercetin, luteolin, diosmetin, and caly-
cosin. It was also possible to identify flavanones (glycosylated derivatives of eriodictyol),
flavan-3-ols (derived from (epi)catechin) and still other types of no-phenolic compounds
(two lignans and a pentacyclc triterpenoid).
With the study of the composition in organic acids and tocopherols, it was found
that oxalic acid had higher levels for all samples and it is the T1 sample that revealed
the highest total content of organic acids in the dry extract and aqueous preparation.
Regarding tocopherols, it was found that in the aqueous preparation of tisanes, no isoform
was detected due to the lipid character of this molecule and γ-tocopherol was the most
abundant isoform in the dry extract, mainly in T5 sample.
Regarding the results obtained for the various bioactivities studied, it is again the
T5 tisane sample that stands out, revealing the highest capacity for the inhibition of
lipid peroxidation in the TBARS assay, better cytotoxic potential against the MCF-7 cell
line, higher anti-inflammatory activity, and anti-diabetic activity with the inhibition of
α-glucosidase of fungal and animal origin (having been the only one to reveal activity
for the enzyme of animal origin). For the oxidative hemolysis inhibition test, the T2
sample stands out, revealing the lowest IC50 values for 120 and 180 min. However, the T4
sample is the one that revealed the greatest cytotoxic potential for three cell lines, since
it presented lower GI50 values. Regarding antimicrobial activity, the T3 sample showed
the lowest MIC values for Gram-positive bacteria. It should be noted that no sample
revealed hepatotoxicity against the non-tumor line of pig liver cells. Furthermore, none
of the samples showed anti-tyrosinase activity at the maximum tested concentration of
8 mg/mL and for Gram-negative bacteria, the vast majority tisanes did not show very
promising results, as they presented MIC and MBC results higher than the maximum tested
concentration (20 mg/mL).
The presence of lemon thyme in several of the mixtures of MAPs in tisanes may
enhance the most promising results for bioactive activities, since it is present in tisanes
with the best evaluated biological properties. The three tisanes in which the lemon thyme
makes up the mixture are T2, T4, and T5, which are precisely those that stand out with
the highest biological properties. The correlations presented by the Principal Component
Analysis (PCA) reinforce the correlation between the presence of phenolic and non-phenolic
compounds in the five tisanes and its bioactivities.
The antioxidant action of polyphenols presents in tisanes has sparked interest in the
food industry as possible natural substitutes for current artificial antioxidants. In addition
to their recognized bioactive potential, they also have the ability to inhibit oxidative
changes that occur in food. Several groups of polyphenols (anthocyanins, flavanones,
and isoflavones) are currently used in industry as components of nutraceuticals and
functional foods. The interest within the pharmaceutical industry is to find natural products
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obtained from plants in relation to the current artificial compounds available for the
treatment of different health problems. The development of resistance to antimicrobials,
the reappearance of infectious diseases, high production costs, and limited useful life of
therapeutic agents are important factors that have encouraged interest in drugs that include
derivatives of plant extracts.
Studies like the one proposed with this work are extremely important to chemically
characterize the plants commonly used in traditional medicine, adding value to them as
sources of molecules that can later be applied in a wide range of industrial sectors.
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